Canaccord Genuity Reiterates a 'Buy' on Brightpoint (CELL); Update from CTIA: T-Mobile an Overhang, But Stock Attractive
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Brightpoint (NASDAQ: CELL), PT $18.
Canaccord analyst says, "We hosted investor meetings with CEO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "We hosted investor meetings with CEO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
